Sramek Insight

Our Leadership Team

Our team combined with technology experts, data scientists
and professionals in medical and healthcare sector, to guide
our mission and to develop smart healthcare devices for
improving outcome from medical and wellness perspective.

Toney KM Lam, MBA

Group CEO – Sramek Group Inc.
Premium Member – American Heart Association
Committee Director – HKFSCI
Corporate Member – HKBMIA
Member – HKMHDIA

Ir. Victor Ho

Head of product in Geberit
Product Manager in Nokia
Project Manager in Fujikon
Project Engineer in Rockapetta

Prof. Vellaisamy Roy

Professor in City University of Hong Kong
Professor in University of Glasgow
Scientist in Intelligent System
Inventor of medical micro fiber

Dr. Srinivas Bhylahalli

CEO – Intellimed Healthcare
Commercial Lead in SingHealth
CEO Asia at Anatomics
Cofounder – TriSail Medical

Prof. Tao Jun

Principal of Cardiovascular in ZH in GZ
Vice President of National Hypertension Center
Medical Advisor in NMPA
Scientist in GZ Bio-island Laboratory

Dr. Suvendra Das

General Manager Asia – Philips Healthcare
General Manager – HP India

Our strategic partners

We are global

China
Hong Kong
Singapore
USA

Medical Paper Reference

Cardiac index assessment: Validation of a new non-invasive very low current thoracic bioimpedance device by thermodilution

LINK

Hemodynamic monitoring using thoracic bioimpedance – an optimal solution for the treatment of hypertension

LINK

Sustained Cardiovascular Actions of APJ Agonism During Renin–Angiotensin System Activation and in Patients With Heart Failure

LINK

Hemodynamic differences among hypertensive patients with and without heart failure using impedance cardiography

LINK

Our story

The leading TEB (Thoracic Electrical Bioimpedance) technology was invented by Dr. Bo Sramek. It was confirmed by clinical studies to be a legitimate non-invasive counterpart for measurement of CO. NASA (National Aeronautics and Space Administration) appointed Dr. Bo Sramek as a principal investigator in 1985, to develop a device to monitor the heart performance of astronauts in space mission. The technology code name was NCCOM3.

In 1994, the NCCOM3 was enhanced in both accuracy and precision level and later re-packaged as BioZ. It was widely adopted by company like Cheertah, Philips Healthcare, Edward Lifescience and CAS Medical. They then developed their own hemodynamics devices in the Market.

In 1998, Dr. Bo Sramek further upgrade the outcome of BioZ and newly formed a company called Hemo Sapiens Inc. At the same time, the product was named as TEBCO (Hardware) and HOTMAN System (Software). HOTMAN System integrated with innovative data algorithms, which could clearly state the underlying causes of hypertension and recommended drug selection guide.

In 2018, Dr. Bo Sramek partnered with Mr. Toney Lam to form a new company “Sramek BioDynamics Inc.” to acquire all intellectual property of Hemo Sapiens Inc. and re-invented the HOTMAN System with cloud computing capability. With medical AI, HOTMAN system can predict and resolve the medical issues of hypertension in a highly effective and interactive ways.

In 2022, Mr. Toney Lam partnered with Professor Vellaisamy to form the company “Sramek Insight” with a mission to build a smart hemodynamics device for everyone, who can be easily to used at home, to monitor blood flow, blood pressure as well as to alert early stage of heart failure and stroke.